A man with HIV has gone into remission after receiving bone marrow from his brother, who has a rare mutation that prevents ...
That’s why they turn to simulations, like this one, which tracks how a bacterial cell divides into two. The simulation tries ...
A burgeoning field is launching its first clinical trial to find out whether dialing back cell development can safely refresh ...
The patient was bedridden and needed daily blood transfusions, and she had tried nine different therapies that didn't bring ...
CAR-T cell therapy, originally developed for cancer, is showing ever more promise as a treatment for autoimmune diseases.
Understanding the differences between biochemical and cell-based assays is key to choosing the right high-throughput ...
Virica Biotech (“Virica”), a cell enhancer company specializing in Viral Sensitizers (VSE™) for viral vector manufacturing, today announced it is receiving advisory services and funding from the ...
Once the most successful mRNA-based LNP was tested in 3D in vitro models, the fluorescent dye continued to facilitate ...
Backed by OrbiMed, Novartis’ venture arm and many other investors, the biotech is among those working on newer technology ...
As gene therapies advance toward indications with larger patient populations, adeno-associated virus (AAV) manufacturers are under growing pressure to deliver high-quality vectors at substantially ...
As lentiviral vector (LVV) programs advance toward larger clinical trials and commercialization, manufacturing platforms and ...
University of Michigan researchers developed serum albumin-based nanoparticles that delivered plasmid DNA and mRNA into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results